Characterisation of lymphocyte responses to Ca 2+ in Scott syndrome

2 downloads 51 Views 837KB Size Report
Dear Sir,. Scott syndrome (OMIM: 2S2890) (1) is a rare bleeding disorder characterised by a failure of phosphatidylserine (mS) exposure and microvesiculation ...
© 2004 Schattauer GmbH, Stuttgart

Lettersto Letter tothe theEditor Editor Characterisation of lymphocyte responses to Ca2+ in Scott syndrome

Dear Sir, pÅçíí ëóåÇêçãÉ EljfjW OSOUVMF ENF áë ~ ê~êÉ ÄäÉÉÇáåÖ ÇáëçêÇÉê ÅÜ~ê~ÅíÉêáëÉÇ Äó ~ Ñ~áäìêÉ çÑ éÜçëéÜ~íáÇóäëÉêáåÉ EmpF ÉñéçëìêÉ ~åÇ ãáÅêçîÉëáÅìä~íáçå Äó ÜÉã~íçéçáÉíáÅ ÅÉääë ÑçääçïáåÖ ëíáãìJ ä~íáçå ïáíÜ Å~äÅáìã áçåçéÜçêÉ çê éÜóëáçäçÖáÅ~ä ~ÖçåáëíëK ^ë ÉñJ éçëÉÇ mp ~Åíë ~ë ~ ÄáåÇáåÖ ëáíÉ Ñçê íÜÉ íÉå~ëÉ ~åÇ éêçíÜêçãÄáJ å~ëÉ ÅçãéäÉñÉë çÑ íÜÉ ÄäççÇ Åç~Öìä~íáçå Å~ëÅ~ÇÉ EOF áíë íê~åëäçJ Å~íáçå íç íÜÉ ÅÉää ëìêÑ~ÅÉ áë ÅêìÅá~ä áå íÜÉ êÉÖìä~íáçå çÑ Ü~Éãçëí~J ëáëK pÅçíí ëóåÇêçãÉ áë ÖÉåÉê~ääó ÄÉäáÉîÉÇ íç ÄÉ áåÜÉêáíÉÇ ~ë ~å ~ìíçëçã~ä êÉÅÉëëáîÉ íê~áí EPI QFI ÜçïÉîÉêI áíë ãçäÉÅìä~ê Ä~ëáë áë ìåâåçïåK tÜáäëí ãìÅÜ É~êäó ïçêâ ÑçÅìëëÉÇ çå éçíÉåíá~ä ÇÉÑÉÅíë áå éÜçëéÜçäáéáÇ íê~åëäçÅ~íáçå Äó ëÅê~ãÄä~ëÉI ÑìåÅíáçå ~åÇ ok^ äÉîÉäë Ñçê íÜáë éêçíÉáå ~ééÉ~ê åçêã~ä áå pÅçíí ÅÉääë ERI SFK fí Ü~ë ~äëç ÄÉÉå ëìÖÖÉëíÉÇ íÜ~í íÜÉ ÇáëçêÇÉê êÉÑäÉÅíë áãé~áêÉÇ `~OH ìéJ í~âÉ ETFI íÜçìÖÜ íÜÉ ÖÉåÉê~äáíó çÑ ëìÅÜ ~ ÇÉÑÉÅí Ü~ë ÄÉÉå ÇáëéìíJ ÉÇ EUFK råíáä êÉÅÉåíäóI çåäó íïç ÇçÅìãÉåíÉÇ Å~ëÉë EçåÉ ^ãÉêáÅ~åI çåÉ cêÉåÅÜF Ü~îÉ ÄÉÉå êÉéçêíÉÇ ENI PFK eçïÉîÉêI ~ íÜáêÇ EtÉäëÜF é~J íáÉåí Ü~ë åçï ÄÉÉå ÇÉëÅêáÄÉÇ EíÜáë êÉéçêí ~åÇ EUFFK qÜÉ é~íáÉåí áë ~ RVJóÉ~êJçäÇ `~ìÅ~ëá~å ÑÉã~äÉ ïáíÜ ~ ãçÇÉê~íÉ ÄäÉÉÇáåÖ éÜÉJ åçíóéÉ ÅÜ~ê~ÅíÉêáëÉÇ Äó éçëíJé~êíìã Ü~ÉãçêêÜ~ÖÉ ~åÇ ÄäÉÉÇáåÖ ÑçääçïáåÖ ÇÉåí~ä Éñíê~ÅíáçåëK `ç~Öìä~íáçå ëÅêÉÉåáåÖ íÉëíëI éä~íÉäÉí ÅçìåíI ÄäÉÉÇáåÖ íáãÉI áåÇáîáÇì~ä Åç~Öìä~íáçå Ñ~Åíçê ~ÅJ íáîáíó ~ëë~óë ~åÇ éä~íÉäÉí ~ÖÖêÉÖ~íáçå ïÉêÉ ~ää åçêã~äK mêÉîáçìë ëíìÇáÉë Ü~Ç ëÜçïå ~å ~Äåçêã~ä éêçíÜêçãÄáå Åçåëìãéíáçå áåÇÉñ EVFI ïÜáÅÜ Ü~ë êÉã~áåÉÇ ÅçåëáëíÉåíäó ~Äåçêã~ä çîÉê ~ ORJóÉ~ê éÉêáçÇK b_sJíê~åëÑçêãÉÇ _ äóãéÜçÄä~ëíë Ñêçã pÅçíí ëóåÇêçãÉ é~íáÉåíë Ü~îÉ éêÉîáçìëäó ÄÉÉå ëÜçïå íç Ü~îÉ ~ ÇÉÑÉÅí áå mp ÉñJ íÉêå~äáë~íáçå ~åÇ íÜáë éÜÉåçíóéÉ áë Çá~ÖåçëíáÅ çÑ pÅçíí ëóåÇêçãÉ ENMFK tÉ íÜÉêÉÑçêÉ Åçãé~êÉÇ íÜÉ êÉëéçåëÉ çÑ b_s íê~åëÑçêãÉÇ _ ÅÉää äáåÉë Ñêçã íÜÉ tÉäëÜ é~íáÉåí ~åÇ Åçåíêçäë íç ëíáãìä~íáçå

Correspondence to: Dr. James Elliott Membrane Transport Biology Group MRC Clinical Sciences Centre Faculty of Medicine Imperial College Hammersmith Hospital Campus Du Cane Rd London W12 0NN, UK Tel.: +44 20 8383 8269, Fax: +44 20 8383 8337 E-mail: [email protected] Received July 1, 2003 Accepted after resubmission August 18, 2003

Thromb Haemost 2004; 91: 412 – 5

Figure 1: Responses of Scott and control lymphocytes to calcium ionophore A23187. A) Scott and control EBV transformed B cell lines were equilibrated with annexin VFITC and PI (Becton Dickinson, CA). The cells were analysed by flow cytometric analysis. Baseline fluorescence was established and then cells were stimulated with A23187. Plots depict the change in fluorescence of cell bound Annexin VFITC which is a surrogate marker of PS exposure.To further demonstrate an increase in PS exposure EBV transformed B cells were washed and resuspended with 2 µM human prothrombin, 5 pM human factor Xa and 25 pM human factor V in a volume of 200 µl. Aliquots were withdrawn at various time points before and following the addition of A23187 and assayed for thrombin activity using the chromogenic substrate S-2238. B) Freshly isolated lymphocytes obtained by venepuncture from the Scott patient and controls were washed and resuspended in phenol red-free DMEM (Sigma). Donors of control blood were healthy female volunteers aged between 24 and 60. Blood was collected from the Scott patient on three separate visits to Hammersmith Hospital. Lymphocytes were stained with antiCD4APC and equilibrated with annexin VFITC and PI prior to FACS analysis. After establishing baseline fluorescence, cells were stimulated with A23187. Density plots of annexin VFITC fluorescence in PI– cells staining positively for CD4 are shown and the number of CD4+ cells and their annexin VFITC fluorescence is shown towards the end of the experiment (R1). C) In the same experiment as represented in B, but without restricting analysis to CD4+ lymphocytes, the appearance of small, (forward light scatter low) cells (marked as gate R2) is shown following stimulation of control lymphocytes with A23187. Cells within R2 were annexin VFITCnegative (not shown). In contrast Scott cells stimulated with A23187 showed no appearance of small cells.The relative sizes of control and Scott PI– cells towards the end of the experiment (within gate R3 and similarly gated control cells). Results are representative of three separate experiments. D) Ca2+-uptake by Scott and control lymphocytes was measured by flow cytometric analysis. Lymphocytes labelled with antiCD4APC antibody were incubated with the Ca2+-indicator Fluo-4 AM, after baseline fluorescence was established; Ca2+ uptake was induced with A23187. Increased intracellular Ca2+ in the CD4+ population is indicated by raised Fluo-4 fluorescence (mean + S.E. fluorescence units.Two representative experiments are shown. E) Cell shrinkage in Scott and control lymphocytes was analysed by flow cytometry. Lymphocytes were stained with anti-CD4PE, anti-CD4CYCHROME antibodies in order to distinguish between Scott and control cells. Samples were mixed, baseline flow cytometric parameters established, and stimulated with A23187. Shrinkage of cells positively stained with CD4 antibodies was measured by reduction in forward light scatter.The results of two independent experiments are shown.The data are representative of three comparable experiments performed on separate occasions using three different control subjects.

412

Downloaded from www.thrombosis-online.com on 2015-08-25 | ID: 1000521375 | IP: 195.195.102.91 For personal or educational use only. No other uses without permission. All rights reserved.

Letter to the Editor

413

Downloaded from www.thrombosis-online.com on 2015-08-25 | ID: 1000521375 | IP: 195.195.102.91 For personal or educational use only. No other uses without permission. All rights reserved.

Letter to the Editor

ïáíÜ íÜÉ Å~äÅáìã áçåçéÜçêÉ ^OPNUTK få Åçåíê~ëí íç íÜÉ Åçåíêçä ÅÉää äáåÉI b_sJíê~åëÑçêãÉÇ _ ÅÉääë Ñêçã íÜÉ é~íáÉåí ÉñÜáÄáíÉÇ ~ ã~êâÉÇäó ÇÉä~óÉÇ áåÅêÉ~ëÉ áå éêçíÜêçãÄáå~ëÉ ~ÅíáîáíóI ïÜáäëí ÄáåÇáåÖ íç ÑäìçêÉëÅÉåíäó ä~ÄÉääÉÇ ~ååÉñáå s ï~ë ëÉîÉêÉäó ÇáãáåJ áëÜÉÇ áå ãìäíáéäÉ ÉñéÉêáãÉåíë EcáÖ N^FI ÅçåÑáêãáåÖ íÜÉ Çá~ÖåçJ ëáë çÑ pÅçíí ëóåÇêçãÉK mêçíÜêçãÄáå~ëÉ ~Åíáîáíó ~åÇ Eçå ëçãÉ çÅJ Å~ëáçåëF ÄáåÇáåÖ çÑ ~ååÉñáå s ï~ë ÇÉä~óÉÇ ê~íÜÉê íÜ~å ~ÄçäáëÜÉÇ ~åÇ ~ë íÜáë î~êá~Äáäáíó ãáÖÜí êÉÑäÉÅí ÅÉää ÅìäíìêÉJÇÉéÉåÇÉåí ~êíÉJ Ñ~ÅíëI ïÉ ~ëëÉëëÉÇ íÜÉ êÉëéçåëÉ çÑ ÑêÉëÜäó áëçä~íÉÇ äóãéÜçÅóíÉë íç ^OPNUTK ióãéÜçÅóíÉë Ñêçã íÜÉ pÅçíí ëóåÇêçãÉ é~íáÉåí ~åÇ Åçåíêçäë ïÉêÉ áëçä~íÉÇ áå é~ê~ääÉäI ~åÇ ëí~áåÉÇ ïáíÜ ~åíáJ`aQ qJ ÅÉää ëéÉÅáÑáÅ ~åíáÄçÇáÉë E_ÉÅíçå aáÅâáåëçåI `^F áëçä~íáåÖ íÜÉ êÉJ ëéçåëÉ çÑ ~ êÉä~íáîÉäó ÜçãçÖÉåÉçìë éçéìä~íáçå çÑ ÅÉääë Äó Ñäçï ÅóíçãÉíêáÅ ~å~äóëáëK ^ééêçéêá~íÉäó ä~ÄÉääÉÇ äóãéÜçÅóíÉë ïÉêÉ íÜÉå ÉáíÜÉê ÉèìáäáÄê~íÉÇ ïáíÜ ÑäìçêÉëÅÉåíäó ä~ÄÉääÉÇ ~ååÉñáå s E^sX _ÉÅíçå aáÅâáåëçåI `^F çê ãáñÉÇ ëìÅÜ íÜ~í pÅçíí ~åÇ ÅçåJ íêçä äóãéÜçÅóíÉë ÅçìäÇ ÄÉ ÇáëíáåÖìáëÜÉÇ çå íÜÉ Ä~ëáë çÑ ÄáåÇáåÖ íç ÇáÑÑÉêÉåíäó ä~ÄÉääÉÇ ÑäìçêÉëÅÉåí ~åíáÄçÇáÉëI ~åÇ íÜÉå ÉèìáäáJ Äê~íÉÇ ïáíÜ ^sK _~ëÉäáåÉ ÑäìçêÉëÅÉåÅÉ ï~ë Éëí~ÄäáëÜÉÇ éêáçê íç ~ÇÇáíáçå çÑ ^OPNUT íç áåáíá~íÉ mp íê~åëäçÅ~íáçåK jìäíáé~ê~ãÉíÉê Ñäçï ÅóíçãÉíêáÅ ~å~äóëáë éÉêãáííÉÇ ëáãìäí~åÉçìë ~å~äóëáë çÑ ÅÉää ãÉãÄê~åÉ éÉêãÉ~Äáäáíó EéêçéáÇáìã áçÇáÇÉ xmfz ìéí~âÉI ~å áåÇáJ Å~íçê çÑ ÅÉää ÇÉ~íÜFI ÅÉää îçäìãÉ EÑçêï~êÇ äáÖÜí ëÅ~ííÉêFI ~åÇ mp ÉñéçëìêÉ íç íÜÉ ÅÉää ëìêÑ~ÅÉ E^scfq` ÄáåÇáåÖFK ^ë ÉñéÉÅíÉÇI Åçåíêçä äóãéÜçÅóíÉë ÉñÜáÄáíÉÇ ê~éáÇ ÉñéçëìêÉ çÑ mpI ~ë ÉîáJ ÇÉåÅÉÇ Äó ÄáåÇáåÖ çÑ ^s EcáÖK N_FK _ó Åçãé~êáëçåI mp íê~åëäçJ Å~íáçå Äó pÅçíí äóãéÜçÅóíÉë ï~ë ëáÖåáÑáÅ~åíäó ÇÉä~óÉÇI çÅÅìêêÉÇ áå ÑÉïÉê ÅÉääëI ~åÇ íÜÉå ~í ~ êÉÇìÅÉÇ äÉîÉä éÉê ÅÉääK fåíÉêÉëíáåÖäóI ~äíÜçìÖÜ íÜÉ ÇÉÑÉÅí áå mp íê~åëäçÅ~íáçå ï~ë é~êíá~äI ÄäÉÄÄáåÖ ~åÇ ëÜÉÇÇáåÖ çÑ ÄçìåÇ ^s E~ë ÉîáÇÉåÅÉÇ Äó íÜÉ ~ééÉ~ê~åÅÉ çÑ êÉëáÇJ ì~ä ëã~ääI Öê~åìä~ê ~ååÉñáå sJåÉÖ~íáîÉ ÄçÇáÉëF ~ééÉ~êÉÇ ëÉîÉêÉJ äó áãé~áêÉÇ EcáÖK N`FK ^ÄëÉåÅÉ çÑ íÜáë éêçÅÉëëI ïÜáÅÜ ~ééÉ~êë íç ÅäçëÉäó Ñçääçï íÜÉ áåáíá~íáçå çÑ mp íê~åëäçÅ~íáçåI ~ééÉ~êë íÜÉ ãçëí ã~êâÉÇ ÅÜ~ê~ÅíÉêáëíáÅ çÑ äóãéÜçÅóíÉë Ñêçã íÜáë pÅçíí ëóåJ ÇêçãÉ é~íáÉåíK få Åçåíê~ëí íç ëçãÉ ETFI Äìí áå ~ÖêÉÉãÉåí ïáíÜ çíÜÉêë EUF ïÉ ïÉêÉ ìå~ÄäÉ íç ÑáåÇ ~åó ÅçåëáëíÉåí ÇáÑÑÉêÉåÅÉ áå `~OH ìéí~âÉ ÄÉíïÉÉå b_sJíê~åëÑçêãÉÇ pÅçíí äóãéÜçÅóíÉë ~åÇ Åçåíêçäë Eåçí ëÜçïåFK qç Åçãé~êÉ íÜÉ êÉëéçåëÉ çÑ ÑêÉëÜäó áëçä~íÉÇ äóãéÜçÅóíÉë pÅçíí ~åÇ Åçåíêçä ÅÉääë ïÉêÉ ëí~áåÉÇ ïáíÜ ~åíáJ`aQ ~åíáÄçÇóI ï~ëÜÉÇ ~åÇ ëìÄëÉèìÉåíäó ÉáíÜÉê íêÉ~íÉÇ ëÉé~ê~íÉäó çê ãáñÉÇK ióãéÜçJ ÅóíÉë ïÉêÉ áåÅìÄ~íÉÇ ïáíÜ íÜÉ `~OHJêÉëéçåëáîÉ ÑäìçêÉëÅÉåí áåÇáJ Å~íçê cäìçJQ ^j EMKP ”jçäLi jçäÉÅìä~ê mêçÄÉëF Ñçê NR ãáåìíÉëI ï~ëÜÉÇ íïáÅÉ ~åÇ êÉëìëéÉåÇÉÇ áå éÜÉåçä êÉÇJÑêÉÉ ajbjK

fçåçéÜçêÉJáåÇìÅÉÇ `~OH ìéí~âÉ Äó ÑêÉëÜäó áëçä~íÉÇ äóãéÜçJ ÅóíÉë Ñêçã íÜÉ pÅçíí é~íáÉåí ï~ë Éèì~ä íçI çê ã~êÖáå~ääó ÖêÉ~íÉê íÜ~å íÜ~í Äó Åçåíêçäë ÅÉääë EcáÖK NaFI ÉîÉå ïÜÉå áåÅìÄ~íÉÇ ïáíÜ cäìçJQ ^j áå ~ ëáåÖäÉ íìÄÉ íç ÉåëìêÉ Éèìáî~äÉåí äç~ÇáåÖK páãáä~ê êÉëìäíë ïÉêÉ ÑçìåÇ Ñçê `aNVH _ äóãéÜçÅóíÉë EÇ~í~ åçí ëÜçïåFK ^äíÜçìÖÜ ïÉ ÑçìåÇ `~OH ìéí~âÉ íç ÄÉ åçêã~ä áå ÅÉääë Ñêçã íÜÉ pÅçíí é~íáÉåíI áå ~ÖêÉÉãÉåí ïáíÜ ~ êÉÅÉåí êÉéçêí EUFI áí êÉã~áåÉÇ éçëëáÄäÉ íÜ~í pÅçíí äóãéÜçÅóíÉë ~êÉ `~OHJìåêÉëéçåëáîÉK qç áåJ îÉëíáÖ~íÉ íÜáë ~åÇ íç ~ëÅÉêí~áå ïÜÉíÜÉê ~ pÅçííJëéÉÅáÑáÅ äÉëáçå çÅJ ÅìêêáåÖ éêáçê íç mp ÉñéçëìêÉ ÅçìäÇ ÄÉ áÇÉåíáÑáÉÇI ïÉ Åçãé~êÉÇ íÜÉ ê~íÉ çÑ áçåçéÜçêÉJëíáãìä~íÉÇ ÅÉää ëÜêáåâ~ÖÉ áå ÑêÉëÜäó áëçä~íJ ÉÇ ÅÉääëK `Éää ëÜêáåâ~ÖÉI ~ÅÜáÉîÉÇ Äó ÉÑÑäìñ çÑ hH ~åÇ `äÓ áçåë ~åÇ íÜÉ ÅçåëÉèìÉåí äçëë çÑ ï~íÉêI éêÉÅÉÇÉë mp íê~åëäçÅ~íáçå ENNFI ~åÇ çÅÅìêêÉÇ ê~éáÇäó ÑçääçïáåÖ ëíáãìä~íáçå ïáíÜ ^OPNUT EcáÖK NbFK qÜçìÖÜ ãáåçê ÇáÑÑÉêÉåÅÉë ïÉêÉ ~éé~êÉåí áå áåáíá~ä ÅÉää îçäJ ìãÉë EïÜáÅÜ ~ééÉ~êë íç êÉÑäÉÅí åçêã~ä ÄáçäçÖáÅ~ä î~êá~íáçåFI ~ë íÜÉ ê~íÉ ~åÇ ÉñíÉåí çÑ îçäìãÉ ÇÉÅêÉ~ëÉ çÑ é~íáÉåí ~åÇ Åçåíêçä ÅÉääë ï~ë Éèìáî~äÉåíI äóãéÜçÅóíÉë Ñêçã íÜáë pÅçíí ëóåÇêçãÉ é~J íáÉåí ÉñÜáÄáí E~í äÉ~ëí ëçãÉF åçêã~ä êÉëéçåëÉë íç `~OH éêáçê íç mp íê~åëäçÅ~íáçåK aÉÑÉÅíáîÉ `~OH ìéí~âÉ Äó b_sJíê~åëÑçêãÉÇ _ äóãéÜçÅóíÉë Ñêçã íÜÉ cêÉåÅÜ é~íáÉåí ã~ó êÉÑäÉÅí å~íìê~ä ÄáçäçÖJ áÅ~ä î~êá~íáçåI ~ÖÉJÇÉéÉåÇÉåí ÇÉÅêÉ~ëÉÇ äóãéÜçÅóíÉ êÉëéçåëáîÉJ åÉëëI çê ÇáÑÑÉêÉåÅÉë áå íÜÉ ìåÇÉêäóáåÖ ÇÉÑÉÅíë áå äóãéÜçÅóíÉë Ñêçã íÜÉ cêÉåÅÜ ~åÇ çíÜÉê pÅçíí é~íáÉåíëK qç ëìãã~êáëÉI ïÉ Ü~îÉ éêÉëÉåíÉÇ íÜÉ Ñáêëí ÑìåÅíáçå~ä ~å~äóëáë çÑ ÑêÉëÜäó áëçä~íÉÇ pÅçíí äóãéÜçÅóíÉë ~åÇ ÑáåÇ åç ÉîáÇÉåÅÉ íÜ~í ÉáJ íÜÉê `~OH ìéí~âÉ çê íÜÉ É~êäáÉëí êÉëéçåëÉë íç `~OH ~êÉ ÇÉÑÉÅíáîÉK qÜçìÖÜ mp íê~åëäçÅ~íáçå ï~ë ÇáãáåáëÜÉÇ áå äóãéÜçÅóíÉëI ÅçãJ éäÉíÉ ~ÄëÉåÅÉ çÑ ãáÅêçîÉëáÅìä~íáçå ï~ë íÜÉ ÅäÉ~êÉëí éÜÉåçíóéÉI ëìééçêíáåÖ ëíìÇáÉë ëìÖÖÉëíáåÖ íÜ~í íÜÉ íïç éêçÅÉëëÉë ~êÉ áåíáJ ã~íÉäó äáåâÉÇ ENOFK få ÅçåàìåÅíáçå ïáíÜ éêÉîáçìë ÑáåÇáåÖëI íÜÉ Ç~í~ ~êÉ ÅçåëáëíÉåí ïáíÜ ~ ãçÇÉä áå ïÜáÅÜ mp íê~åëäçÅ~íáçå áë éçJ íÉåíá~íÉÇ ÄóI Äìí åçí ÉåíáêÉäó ÇÉéÉåÇÉåí çå ÅÉää ãÉãÄê~åÉ ëíêìÅJ íìê~ä ÅÜ~åÖÉë êÉèìáêÉÇ Ñçê ÄäÉÄÄáåÖI ~åÇ íÜ~í ~ ÇÉÑÉÅí áå íÜÉ ä~íJ íÉê éêçÅÉëë áë íÜÉ éêáåÅáé~ä ÇÉÑÉÅí áå ÅÉääë Ñêçã íÜÉ åÉï pÅçíí é~J íáÉåíK Acknowledgement tÉ ïçìäÇ äáâÉ íç íÜ~åâ íÜÉ é~íáÉåí Ñçê ÜÉê ÜÉäé áå íÜáë ëíìÇóK

James I. Elliott, Andrew D. Mumford, Christiane Albrecht, Peter W. Collins, John C. Giddings, Christopher F. Higgins, Edward G. D.Tuddenham, John H. McVey

References NK tÉáëë egI sáÅáÅ tgI i~ÖÉë _^I Éí ~äKK fëçä~íÉÇ ÇÉÑáÅáÉåÅó çÑ éä~íÉäÉí éêçÅç~Öìä~åí ~ÅíáîáíóK ^ã g jÉÇ NVTVX STW OMSJNPK OK dáäÄÉêí dbI ^êÉå~ ^^K ^Åíáî~íáçå çÑ íÜÉ Ñ~Åíçê sfff~JÑ~Åíçê fu~ ÉåòóãÉ ÅçãéäÉñ çÑ ÄäççÇ ÅçJ ~Öìä~íáçå Äó ãÉãÄê~åÉë Åçåí~áåáåÖ éÜçëJ

éÜ~íáÇóäJiJëÉêáåÉK g _áçä `ÜÉã NVVSX OTNW NNNOMJRK PK qçíá cI p~íí~ kI cêÉëëáå~ìÇ bI Éí ~äKK pÅçíí ëóåJ ÇêçãÉI ÅÜ~ê~ÅíÉêáòÉÇ Äó áãé~áêÉÇ íê~åëãÉãJ Äê~åÉ ãáÖê~íáçå çÑ éêçÅç~Öìä~åí éÜçëJ éÜ~íáÇóäëÉêáåÉ ~åÇ ÜÉãçêêÜ~ÖáÅ ÅçãéäáÅ~J

íáçåëI áë ~å áåÜÉêáíÉÇ ÇáëçêÇÉêK _äççÇ NVVSX UTW NQMVJNRK QK tÉáëë egI i~ÖÉë _K c~ãáäó ëíìÇáÉë áå pÅçíí ëóåÇêçãÉK _äççÇ NVVTX UTW QTRJSK RK wÜçì nI páãë mgI táÉÇãÉê qK bñéêÉëëáçå çÑ éêçíÉáåë ÅçåíêçääáåÖ íê~åëÄáä~óÉê ãçîÉãÉåí çÑ

414

Downloaded from www.thrombosis-online.com on 2015-08-25 | ID: 1000521375 | IP: 195.195.102.91 For personal or educational use only. No other uses without permission. All rights reserved.

Letter to the Editor éä~ëã~ ãÉãÄê~åÉ éÜçëéÜçäáéáÇë áå íÜÉ _ äóãJ éÜçÅóíÉë Ñêçã ~ é~íáÉåí ïáíÜ pÅçíí ëóåÇêçãÉK _äççÇ NVVUX VOW NTMTJNOK SK píçìí gdI _~ëëÉ cI iìÜã o^I Éí ~äKK pÅçíí ëóåJ ÇêçãÉ ÉêóíÜêçÅóíÉë Åçåí~áå ~ ãÉãÄê~åÉ éêçJ íÉáå Å~é~ÄäÉ çÑ ãÉÇá~íáåÖ `~OHJÇÉéÉåÇÉåí íê~åëÄáä~óÉê ãáÖê~íáçå çÑ ãÉãÄê~åÉ éÜçëéÜçJ äáéáÇëK g `äáå fåîÉëí NVVTX VVW OOPOJUK TK j~êíáåÉò j`I j~êíáå pI qçíá cI Éí ~äKK páÖåáÑáJ Å~åÅÉ çÑ Å~é~Åáí~íáîÉ `~OH Éåíêó áå íÜÉ êÉÖìä~J íáçå çÑ éÜçëéÜ~íáÇóäëÉêáåÉ ÉñéêÉëëáçå ~í íÜÉ ëìêÑ~ÅÉ çÑ ëíáãìä~íÉÇ ÅÉääëK _áçÅÜÉãáëíêó NVVVX PUW NMMVOJUK

UK jìååáñ f`I e~êãëã~ jI dáÇÇáåÖë g`I Éí ~äKK píçêÉJãÉÇá~íÉÇ Å~äÅáìã Éåíêó áå íÜÉ êÉÖìä~íáçå çÑ éÜçëéÜ~íáÇóäëÉêáåÉ ÉñéçëìêÉ áå ÄäççÇ ÅÉääë Ñêçã pÅçíí é~íáÉåíëK qÜêçãÄ e~Éãçëí OMMPX UVW SUTJVRK VK m~êêó aeI dáÇÇáåÖë g`I _äççã ^iK c~ãáäá~ä Ü~Éãçëí~íáÅ ÇÉÑÉÅí ~ëëçÅá~íÉÇ ïáíÜ êÉÇìÅÉÇ éêçíÜêçãÄáå ÅçåëìãéíáçåK _ê g e~Éã~íçä NVUMX QQW POPJPQK NMK hçàáã~ eI kÉïíçåJk~ëÜ aI tÉáëë egI Éí ~äKK mêçÇìÅíáçå ~åÇ ÅÜ~ê~ÅíÉêáò~íáçå çÑ íê~åëJ ÑçêãÉÇ _JäóãéÜçÅóíÉë ÉñéêÉëëáåÖ íÜÉ ãÉãJ

Äê~åÉ ÇÉÑÉÅí çÑ pÅçíí ëóåÇêçãÉK g `äáå fåîÉëí NVVQX VQW OOPTJQQK NNK bääáçíí gfI eáÖÖáåë `cK fh`~N ~Åíáîáíó áë êÉJ èìáêÉÇ Ñçê ÅÉää ëÜêáåâ~ÖÉI éÜçëéÜ~íáÇóäëÉêáåÉ íê~åëäçÅ~íáçå ~åÇ ÇÉ~íÜ áå q äóãéÜçÅóíÉ ~éçéJ íçëáëK bj_l oÉéçêíë OMMOX QW NUVJVQK NOK páãë mgI táÉÇãÉê qI bëãçå `qI Éí ~äKK ^ëëÉãJ Ääó çÑ íÜÉ éä~íÉäÉí éêçíÜêçãÄáå~ëÉ ÅçãéäÉñ áë äáåâÉÇ íç îÉëáÅìä~íáçå çÑ íÜÉ éä~íÉäÉí éä~ëã~ ãÉãÄê~åÉK píìÇáÉë áå pÅçíí ëóåÇêçãÉW ~å áëçJ ä~íÉÇ ÇÉÑÉÅí áå éä~íÉäÉí éêçÅç~Öìä~åí ~ÅíáîáíóK g _áçä `ÜÉã NVUVX OSQW NTMQVJRTK

Erratum

få íÜÉ ~êíáÅäÉ Äó h~åÉáÇÉêI Éí ~äK ÉåíáíäÉÇ póåÇÉÅ~åJQJ ÇÉéÉåÇÉåí ëáÖå~äáåÖ áå íÜÉ áåÜáÄáíáçå çÑ ÉåÇçíçñáåJáåÇìÅÉÇ ÉåÇçíÜÉäá~ä ~ÇÜÉêÉåÅÉ çÑ åÉìíêçéÜáäë Äó ~åíáíÜêçãÄáåÒ éìÄäáëÜÉÇ áå qÜêçãÄçëáë ~åÇ e~Éãçëí~ëáë aÉÅÉãÄÉê OMMP EqÜêçãÄ e~Éãçëí OMMPX VMW NNRMJTF íÜÉ ÑçääçïáåÖ Éêêçê ï~ë ã~ÇÉW

Materials and methods

qÜÉ éêÉé~ê~íáçå çÑ ~åíáíÜêçãÄáå ìëÉÇ Ñçê íÜÉ ëíìÇó ï~ë îáêìëJ áå~Åíáî~íÉÇ Üìã~å éä~ëã~íáÅ ~åíáíÜêçãÄáå fff ÅçåÅÉåíê~íÉ E^îÉåíáë _ÉÜêáåÖI j~êÄìêÖI dÉêã~åóFK

415

Downloaded from www.thrombosis-online.com on 2015-08-25 | ID: 1000521375 | IP: 195.195.102.91 For personal or educational use only. No other uses without permission. All rights reserved.